Abbreviations used in this paper: AID, α~1~ interaction domain; RGK, Rad, Rem, Rem2, Gem/Kir.

INTRODUCTION
============

Voltage-gated Ca^2+^ channels are the signature feature of excitable cells, transducing electrical activity into increased intracellular \[Ca^2+^\] that mediates specific cellular effects such as muscle contraction, hormone secretion, and release of neurotransmitters. Thus, many regulatory mechanisms have evolved to fine tune Ca^2+^ channel activity and the resultant Ca^2+^ influx, mostly by protein--protein interactions with, or posttranslational modifications of, the pore-forming α~1~ subunit. Some are rapid, such as Ca^2+^-dependent inactivation of L-type (Ca~V~1.2) channels ([@bib5]); others occur after the activation of signaling pathways, such as PKA potentiation of Ca~V~1.2 channels or G protein inhibition of N-type (Ca~V~2.2) channels ([@bib7]). In contrast, mechanisms that result in finely graded responses to changes in the cellular environment developing over longer time scales have not been well described.

RGK GTPases (Rad, Rem, Rem2, Gem/Kir), the most recently characterized group within the Ras family of GTP-binding proteins ([@bib32]; [@bib26]; [@bib12]; [@bib16]), have received special attention because they are potent inhibitors of Ca^2+^ channels and candidates for Ca^2+^ channel regulators under transcriptional control that can therefore integrate the influence of multiple extracellular signals. Experiments in a variety of cell types have shown a drastic reduction of peak current amplitude for multiple Ca^2+^ channels after expression of Gem/Kir ([@bib4], [@bib3]; [@bib29]; [@bib40]), Rem, Rad ([@bib14]; [@bib9]), and Rem2 ([@bib8]; [@bib15]). Among Ras family members, RGKs differ by having extended variable N-terminal regions and conserved C-terminal extensions lacking the CAAX motif for fatty acylation, and containing binding motifs for calmodulin and 14-3-3 proteins ([@bib21]). Individual RGKs have nonoverlapping patterns of expression, and are transcriptionally induced and repressed by different factors. For example, Gem and Rem2 transcription has been reported to be stimulated by glucose in insulin-secreting pancreatic cells but follow a different time course ([@bib30]; [@bib15]); Rad is overexpressed in muscle of type II diabetics ([@bib32]), and Rem transcription is repressed by lipopolysaccharide exposure ([@bib12]). RGKs also vary in their downstream targets. Gem inhibits the Rho/RhoA kinase pathway ([@bib41]) and induces neuroblastoma morphological and ganglionic differentiation ([@bib24]). Expression of both Gem and Rem2 has been shown to decrease glucose-stimulated insulin secretion ([@bib4]; [@bib15]).

Models for how RGKs potently inhibit Ca^2+^ channels are controversial. A two-hybrid experiment identified Ca^2+^ channel β subunits as a Gem-interacting protein in the insulin-secreting MIN6 cell line ([@bib4]). Since β subunits have been implicated in trafficking α~1~ subunits to the plasma membrane, this led to the hypothesis that RGKs prevent β subunits from interacting with α~1~ subunits, thereby preventing membrane targeting and resulting in reduced channels at the cell surface ([@bib4], [@bib2],[@bib3]). A number of recent studies suggest instead that RGKs inhibit channels already resident at the cell surface ([@bib8]; [@bib15]). Moreover, though it is their potency that has earned them interest, it is a more subtle and tunable response that likely has physiological ramifications. It has already been established that changes in Ca^2+^ channel currents less severe than the near complete reduction observed when RGKs are expressed in heterologous systems lead to drastic pathophysiological consequences ([@bib35]). It is difficult to understand how RGK expression could result in a finely graded response.

In this study, we provide new insights into how Gem and Rem2 regulate Ca^2+^ channels. Exploiting the *Xenopus* oocyte system to control levels of expression ([@bib6]), we found that Gem and Rem2 drive a dose-dependent inhibition of Ca^2+^ currents. Rem2, but not Gem, also modulated both the kinetics of channel activation and inactivation in a manner that was dependent on β subunit interaction with the α~1~ interaction domain (AID). Together, these results suggest that specific RGKs contribute to the fine tuning of Ca^2+^ influx by different mechanisms.

MATERIALS AND METHODS
=====================

Construction of cDNA Plasmids
-----------------------------

Constructs for α~1C~ (pCARDHE), α~2~δ, and the α~1C~ C-terminal deletion (amino acids 1670--2171), and the GST I-II loop have been previously reported ([@bib43]; [@bib22]). β3 (GenBank/EMBL/DDBJ accession no. [NM_000725](NM_000725)) was cloned into the pGEM-HE oocyte expression vector using standard molecular biology techniques. Gem full-length (accession no. [BC018219](BC018219)) was obtained as an EST and cloned into the pCS2+ oocyte expression vector (gift from D. McKinnon, State University of New York, Stony Brook, NY). Rem2 full-length ([AY916790](AY916790)), a gift from D. Andres (University of Kentucky, Lexington, KY), was digested out of the original pCDNA3.1 vector and ligated into compatible sites in pCS2+. The α~1C~ N-terminal deletion (amino acids 2--139) was generated by a PCR-based strategy. The α~1C~•β3 concatemer included amino acids 1--2134 from α~1C~ and the entire β3 with a valine linker between them. The mutant α~1C~ ^Y/W^ and corresponding concatemer included mutations Y467S and W470A created by Quikchange (Stratagene). The KChiP2b clone was a gift from P. Pfaffinger (Baylor College of Medicine, Houston, TX).

Electrophysiological Recordings and Analysis
--------------------------------------------

In vitro cRNA transcription and microinjection into *Xenopus* oocytes has been previously reported ([@bib22]). The following amounts of cRNA were injected: α~1C~ (1 ng), α~2~δ (1 ng), β3 (0.22 ng). The amount of RGKs and KChIP2b cRNA injected is indicated in specific experiments. Two-electrode voltage clamp recordings were performed as previously described ([@bib22]). During recordings, oocytes were constantly superfused with a solution containing 40 mM Ba(OH)~2~ (or 40 mM Ca(OH)~2~ in experiments recording Ca^2+^ currents), 50 mM NaOH, 1 mM KOH, and 10 mM HEPES (adjusted to pH 7.4 with methanesulfonic acid). Recordings were performed with a standard two-electrode voltage clamp configuration using an oocyte clamp OC-725C amplifier (Warner Instrument Corp.) connected through a Digidata 1322A A/D interface (Axon Instruments, Inc.) to a personal computer. Ionic currents were filtered at 1 kHz by an integral 4 pole Bessel filter and sampled 10 kHz and analyzed with Clampfit 9.2. Steady-state inactivation was analyzed with a two-pulse protocol in which a 5-s conditioning pulse (P~1~) from −60 mV to +50 mV was followed by a 100-ms test pulse (P~2~) at +10 mV. Normalized P~2~ values were fitted with a Boltzmann equation (I/I~peak~ = (1 − I~o~)/\[1 + exp((V − V~1/2~)/k)\] + I~o~). Activation time constants were estimated by fitting the activating component of the current trace to the following equation: *I* = *I* ~o~ + A~fast~exp(−t/τ~fast~) + A~slow~exp(−t/τ~slow~). Bursts of pancreatic β cell action potentials were simulated by a 5-s depolarization to −40 mV from −70 mV followed by a series of 26 100-ms voltage-clamp depolarizations between −40 and 0 mV at 5 Hz ([@bib20]). All values are given as means ± SEM, with statistical comparisons performed with a Student\'s *t* test.

Protein Expression/GST Pull-Down Assays
---------------------------------------

Protein expression/GST pull-down assays were performed as previously described ([@bib27]).

Immunoblotting
--------------

Oocytes were injected with either 1,000 pg of Gem cRNA, 1,000 pg Gem cRNA with 1,000 pg cRNA CaM, or 4,000 pg of Gem cRNA. Control oocytes were injected with RNase-free water. Oocytes were incubated at 17°C for 24 h, lysed in ice-cold oocyte extraction buffer (20 mM HEPES, 5 mM KCl, 1.5 mM MgCl~2~, 1 mM EDTA, 10% glycerol, 0.1% NP-40, and Roche protease inhibitor tablets), and then solubilized in SDS. The equivalent of ∼0.2 oocytes was loaded in each lane. Purified bacterial GST and Gem-GST were used in the control lanes. Immunoblotting was performed with an anti-Gem antibody (Abcam).

RESULTS
=======

To explore the mechanisms by which RGKs inhibit Ca^2+^ channel currents, we expressed Ca~V~1.2 channels (α~1C~, α~2~δ, and β3) with Gem, Rem, or Rem2 in *Xenopus* oocytes and recorded the resulting currents by two-electrode voltage clamp. As observed previously, expression of any of these RGKs drastically reduced the *I* ~Ba~ peak current amplitude ([Fig. 1 A](#fig1){ref-type="fig"}, exemplar traces shown in [Fig. 1 D](#fig1){ref-type="fig"}). To distinguish among the possible models by which RGKs inhibit Ca^2+^ currents and to explore the physiological implications, we took advantage of the *Xenopus* oocyte system, in which it has been shown that expression levels of proteins can be accurately titrated in a monotonic fashion ([@bib6]), in order to test whether inhibition were dose dependent. We confirmed this relationship for Gem. [Fig. 1 B](#fig1){ref-type="fig"} demonstrates a monotonic increase in Gem protein with increasing amounts of Gem cRNA injected over the range that we studied. Moreover, coinjection of cRNA for another unrelated protein (calmodulin) did not affect Gem protein levels, suggesting that cRNA amounts in this range did not exceed the protein synthesis capacity in oocytes. With this confirmation, [Fig. 1 C](#fig1){ref-type="fig"} shows that Gem, Rem, and Rem2 inhibit *I* ~Ba~ peak current amplitude at 10 mV in a dose-dependent manner. This was not a nonspecific effect of increasing the amounts of cRNA injection; coexpression of cRNA for KChIP2b, a protein that modulates K^+^ currents and is of similar mass to the RGKs ([@bib1]), did not alter Ca~V~1.2 current amplitude. Examination of individual current traces also revealed differences in the mechanisms by which Gem and Rem2 affect Ca~V~1.2 currents. While coexpression of all three RGKs decreased current amplitude, coexpression of Rem2 also appeared to affect kinetics of activation and inactivation ([Fig. 1 D](#fig1){ref-type="fig"}). Effects of Gem and Rem appeared similar, so we focused on Gem in further studies.

![Dose-dependent inhibition of Ca~V~1.2 channels by Gem and Rem2. (A) Normalized I-V relationships of *I* ~Ba~ from oocytes injected with α~1C~/β3/α~2~δ without or with Gem (130 pg) or Rem2 (936 pg). *n* = 5. (B) Immunoblots with anti-Gem antibody. On left is shown GST and GST-Gem, demonstrating specificity of the antibody. The right panel shows an increase in the amount of Gem protein detected with an increasing amount (as indicated) of cRNA injected per oocyte. Gem is indicated by an arrow; a nonspecific band seen even without injection of Gem cRNA is shown by an asterisk. (C) Dose--response of Gem-, Rem-, or Rem2-mediated inhibition of *I* ~Ba~. KChIP2b cRNA was injected as a negative control. *n* = 5--7. (D) Exemplar traces of Ca~V~1.2 channels expressed without a RGK, with Gem (20 pg), with Rem (100 pg), or with Rem2 (468 pg). Bars: 1 s and 1 μA.](jgp1280605f01){#fig1}

Coexpression of Gem appeared to inhibit Ca~v~1.2 currents by a direct scaling effect, while Rem2 altered the kinetics of activation and inactivation ([Fig. 2 A](#fig2){ref-type="fig"}) in a dose-dependent manner. These different effects upon channel activation and inactivation are better appreciated by examining scaled traces from Ca~V~1.2 channels compared with traces from Ca~V~1.2 channels coexpressed with Gem (26 pg) or Rem2 (936 pg). Rem2 both slowed activation and accelerated inactivation during a 2-s test pulse. Quantitative analysis of the kinetics of inactivation for Ca~V~1.2 channels coexpressed with Rem2 was complicated because the decay phases of currents were contaminated by overlapping slow activation. Thus, we analyzed steady-state inactivation with a two-pulse protocol in which the normalized residual peak current during a +10-mV test pulse (P~2~) was plotted against the voltage of a 5-s inactivating prepulse (P~1~) and found that both Gem (26 pg) and Rem2 (936 pg) affected steady-state inactivation ([Fig. 2 B](#fig2){ref-type="fig"}). The data were fitted to a Boltzmann function with a nonzero pedestal. Rem2 mainly affected the pedestal from 0.23 ± 0.02 to 0.12 ± 0.02, (*n* = 11--12, P \< 0.0001) but Gem reduced the slope to −14.1 ± 0.6 from −9.0 ± 0.8 (*n* = 10--12; P \< 0.0001).

![Rem2 affects channel activation and inactivation. (A) Top panels show exemplar current traces during a 2-s test pulse at +10 mV for Gem and Rem2 at the indicated doses. Bars, 1 μA. The bottom panels show scaled exemplar traces of α~1C~/β3/α~2~δ (gray) coinjected with Gem (65 pg) or Rem2 (936 pg) (black) during a 2-s test pulse to +10 mV. (B) Steady-state inactivation for α~1C~/β3/α~2~δ without or with Gem (26 pg) or Rem2 (936 pg). *n* = 10--12 (C--E) Dose--response of Rem2-mediated effects upon kinetics of activation (τ~fast~, fraction A~slow~, and τ~slow~, respectively, at the indicated test potentials---see legend in **C---**and with the amounts of cRNA injected as indicated on the x-axis), *n* = 7--14. (F) Scaled exemplar traces of activation phases at +10 mV for α~1C~/β3/α~2~δ coexpressed with the indicated Rem2 doses. Bar, 10 ms. (G) Ca^2+^ currents recorded during a simulated burst of action potentials in a pancreatic β cell (see Materials and methods) with no RGK or Rem2 (468 pg). Bars: 200 nA, 1 s.](jgp1280605f02){#fig2}

Rem2 also affected Ca~V~1.2 channel activation in a dose-dependent and voltage-dependent manner ([Fig. 2, C--F](#fig2){ref-type="fig"}). In the absence of Rem2 ([Fig. 2 C](#fig2){ref-type="fig"}, 0 pg), the activating phase for currents elicited with test potentials from 0 to +30 mV was best fitted with two exponentials (*I* = A~fast~e^−τ-fast/t^ + A~slow~e^−τ-slow/t^ + C) and the dominant component was τ~fast~ (fraction A~fast~ was 80--90% at all test potentials; [Fig. 2, C and D](#fig2){ref-type="fig"}). The τ~fast~ decreased with more depolarizing test potentials ([Fig. 2 C](#fig2){ref-type="fig"}), but was unaffected by increasing the dose of coexpressed Rem2. Instead, the slower activation of Ca~V~1.2 channels induced by higher doses of coexpressed Rem2 could be explained by two effects upon τ~slow~: τ~slow~ became longer with increasing doses of Rem2 and the fraction of A~slow~ increased. These effects were most prominent at test potentials near the peak of the I-V curve ([Fig. 2, D and E](#fig2){ref-type="fig"}). The overall consequences of these dose-dependent effects upon activation induced by Rem2 are illustrated by the overlaid traces in [Fig. 2 F](#fig2){ref-type="fig"}.

Since these effects upon channel kinetics suggested that Rem2 could alter the temporal nature of channel responsiveness during action potentials, we tested whether Rem2 altered simulated Ca^2+^-dependent action potentials that underlie the rhythmic bursting of electrical activity essential for insulin secretion in pancreatic islet β cells ([@bib28]). [Fig. 2 G](#fig2){ref-type="fig"} shows the resultant Ca^2+^ currents from Ca~V~1.2 channels (α~1C~, β3, and α~2~δ) expressed in *Xenopus* oocytes during 26 successive 100-ms depolarizations from −40 to 0 mV (at 5 Hz), a protocol that simulates the bursting activity during insulin secretion and has been used in isolated β cells ([@bib20]). In the absence of RGKs, the peak Ca^2+^ current amplitude decreased sequentially during the 26 successive depolarizations so that the current amplitude during the last depolarization was 46 ± 4% (*n* = 8) of the peak current during the first depolarization. Not only were the current amplitudes smaller with coexpression of Rem2 (consistent with the effects of Rem2 presented above), but Rem2 accelerated the decrease in amplitude during the successive depolarizations so that the current amplitude during the last depolarization was 12 ± 7% (*n* = 7; P = 0.001 compared with no RGK) of the peak current during the first depolarization. This accelerated decrement is likely due to the increased rate of inactivation observed in the presence of Rem2 ([Fig. 2 A](#fig2){ref-type="fig"}). In contrast, coexpression of Gem led to decreased current (compared with no RGK), but did not affect the rate of decrement of the current amplitude (unpublished data), consistent with the lack of effect upon channel kinetics shown above. Thus, the presence of Rem2 would decrease the integrated Ca^2+^ influx and alter its kinetics during a burst of action potentials such as those that drive insulin secretion in pancreatic islet β cells.

We next tested whether the α~1C~ N or C termini were necessary for these effects by testing whether deletion constructs (Δ2-139 in the N-terminus or Δ1669-2171 in the C terminus) were modulated by Gem or Rem2. These experiments were prompted in part by a recent report suggesting that Rem, another RGK member, required the α~1C~ C terminus, particularly the PKA phosphorylation site at Ser^1928^, for inhibition of Ca^2+^ channel currents ([@bib9]). In contrast, we found that Gem (250 pg) and Rem2 (936 pg) consistently reduced peak current amplitude for channels containing intact or truncated α~1C~ subunits ([Fig. 3, A and B](#fig3){ref-type="fig"}). Rem2 also maintained its effects upon kinetics of activation and inactivation in the truncated channels, as shown in the scaled exemplar current traces ([Fig. 3 B](#fig3){ref-type="fig"}).

![The Ca^2+^ channel β subunit, but not the α~1C~ N and C termini, are required for Gem- or Rem2-mediated effects. (A and B) Normalized *I* ~Ba~ for the indicated combinations of α~1C~ (WT), the N-terminal truncation (ΔN), or the C-terminal truncation (ΔC), with or with Gem or Rem2, as indicated. All combinations were coexpressed with β3 and α~2~δ. Scaled exemplar current for each pair with (black) or without (gray) Gem or Rem2 are shown on right. *n* = 5--9. Bars: 50 ms (A) and 1 s (B). (C and D) Normalized *I* ~Ba~ for the indicated combinations of ΔC and α~2~δ with or without β3 and Gem or Rem2, as indicated. For the pair without β3, scaled exemplar currents with (black) or without (gray) Gem or Rem2 are shown on right. *n* = 5. Scale bars as above.](jgp1280605f03){#fig3}

We also used the α~1C~ C-terminal deletion to analyze whether β subunits were necessary for Gem or Rem2 modulation. Truncation of the α~1C~ C terminus produces increased current amplitude in the absence of β subunits ([@bib42]; [@bib23]; [@bib17]; [@bib18]), thereby providing a larger baseline current from which to assess RGK inhibition. [Fig. 3 (C and D)](#fig3){ref-type="fig"} shows that, in the absence of a coexpressed β subunit, neither Gem nor Rem2 inhibited channel currents. Further, Rem2 modulated neither activation nor inactivation in the absence of a coexpressed β subunit. These results show that RGK modulation is independent of the α~1C~ N or C terminus, but requires β subunits.

We next tested whether β interaction with the AID was necessary for RGK modulation. Recent models have suggested that RGKs inhibit Ca^2+^ channels by direct competition with β subunits for this high affinity interaction site on the α~1~ subunit ([@bib33]). Although β subunit interaction with the AID is not required for all aspects of β subunit modulation of Ca^2+^ channel function ([@bib27]), AID mutations that block β subunit binding render channel currents too small to accurately assess an inhibitory effect of RGKs ([@bib34]). Building upon a previous hypothesis that the AID--β interaction serves mainly to secure β subunits to α~1~ so as to allow other, lower affinity regulatory interactions, we covalently tethered β subunits directly to the α~1C~ C terminus after amino acid 2134 (α~1C~•β3). Currents from this concatemer (expressed with α~2~δ) were similar to currents from untethered channels (α~1C~ + β3 with α~2~δ), except that the peak of the I-V curve shifted to more depolarized potentials ([Fig. 4 A](#fig4){ref-type="fig"}) as previously reported ([@bib10]). To prevent β3 interaction with AID we made an α~1C~ with two mutations in AID, Y467S and W470A (α~1C~ ^YW^), either of which has been shown to singly disrupt β subunit interaction and block β subunit modulation ([@bib38]; [@bib25]). Confirmation of abolished β subunit binding to the mutant α~1C~ I-II loop is shown in a GST pull-down assay ([Fig. 4 B](#fig4){ref-type="fig"}). Current amplitudes from an α~1C~ subunit with the same mutations coexpressed with β3 (α~1C~ ^YW^ + β3) were very small ([Fig. 4, A, C, and D](#fig4){ref-type="fig"}) and indistinguishable from currents from an α~1C~ expressed without β3 (not depicted), which is consistent with an absence of β3 interaction. When β3 was tethered to the AID mutant (α~1C~ ^YW^•β3) however, the resulting current amplitude was significantly larger than from α~1C~ ^YW^ coexpressed with untethered β3 ([Fig. 4, A, C, and D](#fig4){ref-type="fig"}) Since the requirement for β-AID interaction could be at least partially circumvented by tethering the β subunit to α~1~, this supported the hypothesis that other interactions between α~1~ and β are important for β-dependent modulation. Having generated an α~1C~ subunit that was modulated by a β subunit independent of its AID interaction, we therefore could test whether β-AID was required for RGK inhibition. Currents from channels containing α~1C~•β3 coexpressed with either Gem (250 pg) or Rem2 (628 pg) cRNA showed that they both produced a similar reduction of current as for α~1C~ + β3 (compare [Fig. 1 A](#fig1){ref-type="fig"} with [Fig. 4, D and E](#fig4){ref-type="fig"}). Although coexpression of Gem or Rem2 also reduced currents from channels containing α~1C~ ^YW^•β3, the reduction was much more modest ([Fig. 4, E and F](#fig4){ref-type="fig"}). Moreover, although the effects of Rem2 on activation and inactivation were preserved when coexpressed with α~1C~•β3, Rem2 did not affect activation or inactivation when coexpressed with α~1C~ ^YW^•β3 ([Fig. 4 E](#fig4){ref-type="fig"}). These results show that Rem2-mediated effects upon activation and inactivation require the β-AID interaction while Gem- or Rem2-induced inhibition of current amplitude does not.

![Interaction between the Ca^2+^ channel β subunits and the AID influence Gem- and Rem2-mediated effects. (A) Normalized I-V relationships of *I* ~Ba~ from oocytes injected with the indicated constructs or combinations, all coinjected with α~2~δ. *n* = 31--34. (B) A Hisx6 immunoblot of a pull-down experiment for purified β2 SH3-GK core ([@bib27]) using a GST-α~1C~ I-II or I-II^YW^ mutant loop. Coomassie-stained gel below shows equal loading of the GST fusion proteins. (C) Exemplar traces and models of the indicated concatemers or combinations. Bars: 1 s, 4 μA. (D--F) Normalized *I* ~Ba~ for the indicated concatemers or combinations (all expressed with α~2~δ), with or without Gem or Rem2. Scaled exemplar traces are shown on right. *n* = 5. Bars: 1 s (D and F) and 50 ms (E).](jgp1280605f04){#fig4}

DISCUSSION
==========

Heterologous overexpression of several RGKs in a variety of systems produces almost complete inhibition of coexpressed or endogenous Ca^2+^ channel current ([@bib4], [@bib3]; [@bib14]; [@bib29]; [@bib40]; [@bib8]; [@bib9]) and RGK inhibition of Ca^2+^ influx has been proposed as a mechanism for physiologic control of Ca^2+^ channel activity for responses such as regulation of insulin secretion from pancreatic islet cells ([@bib4]; [@bib15]) or control of cardiac rhythm ([@bib29]). Lacking a detailed molecular understanding of how RGKs could fine tune Ca^2+^ influx eclipses how this mode of regulation could shape a specific physiological response; for example, up-regulation of an RGK ([@bib30]; [@bib15]) and subsequent channel inhibition ([@bib4]; [@bib15]) after glucose stimulation might protect islet cells from excessive Ca^2+^ influx during chronic hyperglycemia, but how would cells retain their ability to secrete insulin with the almost complete loss of Ca^2+^ currents observed in previous overexpression experiments?

In this study we describe two unexpected means by which RGKs regulate Ca^2+^ channels, providing a framework for understanding how a wide array of Ca^2+^ signaling events can be precisely regulated. Exploiting the *Xenopus* oocyte system to control protein expression levels, we found that RGK inhibition of Ca^2+^ channel current was dose dependent. The mechanism(s) by which RGKs lead to current amplitude reduction, previously a source of controversy, is not revealed by these experiments; direct effects upon channels resident at the cell surface ([@bib8]; [@bib15]) or effects upon channel trafficking/assembly ([@bib4]) cannot be easily distinguished by the experiments presented here. The significant finding, however, is that the suppression of current depends upon the level of RGK expression, thus promising a predictable and titratable attenuation of Ca^2+^ current by specific RGKs. Thus, our results suggest that the high glucose-stimulated induction of a specific RGK and the resultant down-regulation of the Ca^2+^ current in pancreatic β islet cells contribute to a protective mechanism against the detrimental effects of an enhanced Ca^2+^ signal resulting from chronic glucose exposure ([@bib19]); conversely, a reduction of RGK protein in response to elevated glucose would serve to compensate hyperglycemia acutely by increasing Ca^2+^ channel activity and consequent insulin secretion.

Furthermore we found that Rem2, but not Gem or Rem, also altered Ca~v~1.2 gating kinetics, slowing activation and enhancing inactivation. These effects upon kinetics suggest that Rem2 must act at least in part upon channels resident at the cell surface. Not only could Rem2 decrease peak Ca^2+^ influx, it could also impart profound influence on the Ca^2+^-dependent action potentials that underlie the rhythmic bursting of electrical activity essential for insulin secretion in pancreatic islet cells ([@bib28]), by shaping the temporal nature of channel responsiveness as suggested by our experiments in [Fig. 2 G](#fig2){ref-type="fig"}. Although the molecular basis for the effects of Rem2 upon channel kinetics is not clear, we speculate that its extended N terminus and C terminus that flank the Ras core may be responsible; neither extension is found in Rem or Gem ([Fig. 5](#fig5){ref-type="fig"}). The kinetic actions of Rem2 could result from an additional contact between Rem2 and the channel within these nonconserved regions.

![Rem2 has extended termini. CLUSTAL W (1.83) multiple sequence alignment ([@bib37]) of Rem, Gem, and Rem2. The gray-boxed areas highlight the extended N and C termini in Rem2 that flank the conserved Ras-like core.](jgp1280605f05){#fig5}

These different modes of regulation by Gem and Rem2, in conjunction with their differential temporal patterns of expression, may yield an integrated response to oppose effects of hyperglycemia. Gem, up-regulated in MIN6 cells within 45 min after exposure to glucose ([@bib30]), would diminish Ca^2+^ influx during acute hyperglycemia; Rem2, induced after 16 h of high glucose ([@bib15]), would serve to shape Ca^2+^ responsiveness during chronic hyperglycemia. Although our experiments were not designed to address the relative potency of Gem vs. Rem2---since their comparative levels in pancreatic β cells have not yet been determined---it is intriguing that Rem2 appears to have a broader dose--response range, which supports the proposed role in fine tuning Ca^2+^ responsiveness over time.

Our study provides several new insights that help clarify the molecular mechanisms by which RGKs inhibit Ca^2+^ channels. First, we demonstrated that β subunits are necessary for RGK inhibition, corroborating previous reports of β subunit dependence ([@bib4]). By using α~1C~ subunits with deletions in either the N or C terminus in order to increase basal current amplitude, we avoided the difficulties of accurately measuring the inhibition of an already small signal, which may explain the contrasting result obtained with Rem ([@bib9]). Second, our experiments with the truncated α~1C~ subunits demonstrated that neither the α~1C~ N terminus nor C terminus were required for Gem- or Rem2-mediated inhibition or alteration of channel gating, also in contrast to a recent report ([@bib9]). While these differences may be attributed to Rem- vs. Rem2-specific effects, failure of the C-terminal deletion (Δ1733) in that report to augment Ca^2+^ currents compared with those from intact α~1C~ subunits, as has been reported previously ([@bib42]; [@bib23]; [@bib17]; [@bib18]), point to possible technical discrepancies.

Our results also help clarify a conflict between two recent biochemical studies concerning whether the AID competes with Ca~v~β for Gem binding ([@bib33]) or is present as a complex with Ca~v~β and Rem ([@bib13]). Our studies support the latter, where the RGKs function only when the α~1~ subunit is in association with a β subunit through its high affinity interaction site AID. In this context, our findings offer additional insights into mechanisms by which β subunits modulate Ca^2+^ channel currents. Coexpression of β subunits with α~1~ subunits increases current amplitude and affects kinetics of activation and inactivation ([@bib11]). Within α~1~ subunits, the major interaction site for β subunits is the AID ([@bib31]). The AID, however, is not absolutely required for all aspects of β subunit modulation as β2a still modulated channel activation and inactivation for an α~1A~ (Ca~v~2.1) subunit in which the AID had been deleted ([@bib27]). Because the W→A mutation in the AID completely blocks β subunit interaction ([@bib25]), our experiments showing that the β subunit-- dependent augmentation of current amplitude is partially preserved with the α~1C~ ^YW^•β3 concatemers demonstrate clearly that β subunits can still modulate Ca^2+^ channels through interactions exclusive of the AID ([@bib39]; [@bib25]; [@bib27]; [@bib36]). Utilization of these concatemers also elucidated the mechanism of RGK modulation of Ca^2+^ channels: the partial preservation of the Gem- or Rem2-mediated decrease in current amplitude with the α~1C~ ^YW^--β3 concatemers rules out models in which RGKs compete with β subunits for AID interaction ([@bib4]; [@bib33]). In contrast, the complete loss of Rem2-mediated effects upon activation and inactivation suggest that the β--AID interaction is necessary only for Rem2-mediated effects upon channel gating.
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